BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38296982)

  • 1. Incorporating longitudinal history of risk factors into atherosclerotic cardiovascular disease risk prediction using deep learning.
    Yu J; Yang X; Deng Y; Krefman AE; Pool LR; Zhao L; Mi X; Ning H; Wilkins J; Lloyd-Jones DM; Petito LC; Allen NB
    Sci Rep; 2024 Jan; 14(1):2554. PubMed ID: 38296982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporating longitudinal history of risk factors into atherosclerotic cardiovascular disease risk prediction using deep learning.
    Yu J; Yang X; Deng Y; Krefman AE; Pool LR; Zhao L; Mi X; Ning H; Wilkins J; Lloyd-Jones DM; Petito LC; Allen NB
    Res Sq; 2023 Oct; ():. PubMed ID: 37886463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Body Mass Index.
    Khera R; Pandey A; Ayers CR; Carnethon MR; Greenland P; Ndumele CE; Nambi V; Seliger SL; Chaves PHM; Safford MM; Cushman M; Xanthakis V; Vasan RS; Mentz RJ; Correa A; Lloyd-Jones DM; Berry JD; de Lemos JA; Neeland IJ
    JAMA Netw Open; 2020 Oct; 3(10):e2023242. PubMed ID: 33119108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing the performance of machine learning and conventional models for predicting atherosclerotic cardiovascular disease in a general Chinese population.
    Fan Z; Du Z; Fu J; Zhou Y; Zhang P; Shi C; Sun Y
    BMC Med Inform Decis Mak; 2023 Jul; 23(1):134. PubMed ID: 37488520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Prediction for Atherosclerotic Cardiovascular Disease With and Without Race Stratification.
    Ghosh AK; Venkatraman S; Nanna MG; Safford MM; Colantonio LD; Brown TM; Pinheiro LC; Peterson ED; Navar AM; Sterling MR; Soroka O; Nahid M; Banerjee S; Goyal P
    JAMA Cardiol; 2024 Jan; 9(1):55-62. PubMed ID: 38055247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of State-of-the-Art Neural Network Survival Models with the Pooled Cohort Equations for Cardiovascular Disease Risk Prediction.
    Deng Y; Liu L; Jiang H; Peng Y; Wei Y; Zhou Z; Zhong Y; Zhao Y; Yang X; Yu J; Lu Z; Kho A; Ning H; Allen NB; Wilkins JT; Liu K; Lloyd-Jones DM; Zhao L
    BMC Med Res Methodol; 2023 Jan; 23(1):22. PubMed ID: 36694118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Socioeconomic status and modification of atherosclerotic cardiovascular disease risk prediction: epidemiological analysis using data from the atherosclerosis risk in communities study.
    Henderson K; Kaufman B; Rotter JS; Stearns S; Sueta CAA; Foraker R; Ho PM; Chang PP
    BMJ Open; 2022 Nov; 12(11):e058777. PubMed ID: 36343998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of the American Heart Association/American College of Cardiology Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Self-reported Physical Activity Levels.
    Pandey A; Mehta A; Paluch A; Ning H; Carnethon MR; Allen NB; Michos ED; Berry JD; Lloyd-Jones DM; Wilkins JT
    JAMA Cardiol; 2021 Jun; 6(6):690-696. PubMed ID: 33909016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining European and U.S. risk prediction models with polygenic risk scores to refine cardiovascular prevention: the CoLaus|PsyCoLaus Study.
    de La Harpe R; Thorball CW; Redin C; Fournier S; Müller O; Strambo D; Michel P; Vollenweider P; Marques-Vidal P; Fellay J; Vaucher J
    Eur J Prev Cardiol; 2023 May; 30(7):561-571. PubMed ID: 36652418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk and added values of the atherosclerotic cardiovascular risk enhancers on prediction of cardiovascular events: Tehran lipid and glucose study.
    Hadaegh F; Asgari S; Moosaie F; Orangi M; Sarvghadi F; Khalili D; Azizi F
    J Transl Med; 2021 Jan; 19(1):25. PubMed ID: 33407576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative performance of the two pooled cohort equations for predicting atherosclerotic cardiovascular disease.
    Campos-Staffico AM; Cordwin D; Murthy VL; Dorsch MP; Luzum JA
    Atherosclerosis; 2021 Oct; 334():23-29. PubMed ID: 34461391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of the 10-year risk of atherosclerotic cardiovascular disease in the Korean population.
    Park S; Kim YG; Ann SH; Cho YR; Kim SJ; Han S; Park GM
    Epidemiol Health; 2023; 45():e2023052. PubMed ID: 37189276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the ACC/AHA Pooled Cohort Cardiovascular Risk Equations in Clinical Practice.
    Medina-Inojosa JR; Somers VK; Garcia M; Thomas RJ; Allison T; Chaudry R; Wood-Wentz CM; Bailey KR; Mulvagh SL; Lopez-Jimenez F
    J Am Coll Cardiol; 2023 Oct; 82(15):1499-1508. PubMed ID: 37793746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of Atherosclerotic Cardiovascular Disease Risk Among Patients in the Veterans Affairs Health Care System.
    Vassy JL; Lu B; Ho YL; Galloway A; Raghavan S; Honerlaw J; Tarko L; Russo J; Qazi S; Orkaby AR; Tanukonda V; Djousse L; Gaziano JM; Gagnon DR; Cho K; Wilson PWF
    JAMA Netw Open; 2020 Jul; 3(7):e208236. PubMed ID: 32662843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between change in cardiovascular risk scores and future cardiovascular disease: analyses of data from the Whitehall II longitudinal, prospective cohort study.
    Lindbohm JV; Sipilä PN; Mars N; Knüppel A; Pentti J; Nyberg ST; Frank P; Ahmadi-Abhari S; Brunner EJ; Shipley MJ; Singh-Manoux A; Tabak AG; Batty GD; Kivimäki M
    Lancet Digit Health; 2021 Jul; 3(7):e434-e444. PubMed ID: 34167764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application of the China-PAR risk prediction model for atherosclerotic cardiovascular disease in a rural northern Chinese population].
    Tang X; Zhang DD; He L; Cao Y; Wang JW; Li N; Huang SP; Dou HD; Gao P; Hu YH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 49(3):439-445. PubMed ID: 28628144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the performance of three cardiovascular disease risk scores: the Estonian Biobank cohort study.
    Saar A; Läll K; Alver M; Marandi T; Ainla T; Eha J; Metspalu A; Fischer K
    J Epidemiol Community Health; 2019 Mar; 73(3):272-277. PubMed ID: 30635435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical risk markers and 10-year incidence of atherosclerotic cardiovascular disease: independent predictors, improvement in pooled cohort equation, and risk reclassification.
    Akintoye E; Briasoulis A; Afonso L
    Am Heart J; 2017 Nov; 193():95-103. PubMed ID: 29129262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on the prediction model of atherosclerotic cardiovascular disease in the rural Xinjiang population based on survival analysis.
    Qian X; Keerman M; Zhang X; Guo H; He J; Maimaitijiang R; Wang X; Ma J; Li Y; Ma R; Guo S
    BMC Public Health; 2023 Jun; 23(1):1041. PubMed ID: 37264356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Analysis of Three Atherosclerotic Cardiovascular Disease Risk Prediction Models in Individuals Aged 75 and Older.
    Wang Z; Yang X; Li L; Zhang X; Zhou W; Chen S
    Clin Interv Aging; 2024; 19():529-538. PubMed ID: 38525315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.